Previous studies have shown that individuals with newly diagnosed systemic lupus erythematosus (SLE) have an increased risk of pulmonary complications. However, these analyses did not consistently account for potential confounding variables. Recent evidence highlights the importance of routine pulmonary screening and emphasizes the need to take a proactive approach to the management of pulmonary problems in this patient group.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management
Trend towards early combination therapy and new strategies for lowering Lp(a)
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment
SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes
- Wearables: screening via smartwatch?